Skip to main content

Table 1 (abstract P137). Clinical and analytical data comparative study

From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

 

Pamidronate

Zoledronate

p-value

Clinical onset

 Fever, n (%)

2 (33,3%)

0

0,051

 Pain, n (%)

6 (100%)

10 (100%)

-

 Swelling, n (%)

2 (33,3%)

6 (60,0%)

0,302

 Number of inflammatory foci, average±SD

2,67±1,75

1,90±0,99

0,278

 Clinical evolution length, median (IQR) (months)

3,00 (1,12-9,75)

0,50 (0,29-7,00)

0,280

Laboratory data

 CRP, median (IQR)

10,00 (7,20-24,55)

5,40 (2,90-17,10)

0,354

 ESR, average±SD

36,20 ± 19,01

26,37 ± 21,06

0,415